NeuroMetrix reports executive management change

Mr Gregory’s resignation will become effective May 31, 2008. In the interim, Mr Gregory will work with Shai Gozani, president and CEO, to transition management of those areas of the business that have been under his direct leadership including marketing, sales and business development.

Mr Gregory’s management responsibilities will be assumed by Mr Gozani. Monty Hukill, vice president of sales, diagnostic devices, Michael MacDonald, vice president of Marketing, and Kevin Quinn, vice president of business development will take on direct day-to-day responsibilities for the company’s sales, marketing, and business development efforts and will report directly to Mr Gozani.